STE STERIS plc

Price (delayed)

$174.80

Market cap

$14.92B

P/E Ratio

34.41

Dividend/share

$1.57

EPS

$5.08

Enterprise value

$16.53B

Sector: Healthcare
Industry: Medical Instruments & Supplies

Steris Corporation is an American Irish-domiciled medical equipment company specializing in sterilization and surgical products for the US healthcare system. Steris is operationally headquartered in Mentor, Ohio, but has been ...

Highlights

The company's equity rose by 14% YoY and by 6% QoQ
The company's net income rose by 10% YoY and by 2.3% QoQ
STE's P/E is 8% below its 5-year quarterly average of 37.6 but 3.3% above its last 4 quarters average of 33.3
STERIS's debt has soared by 60% from the previous quarter and by 48% YoY
STERIS's quick ratio has decreased by 14% from the previous quarter and by 3% YoY

Key stats

What are the main financial stats of STE
Market
Shares outstanding
85.35M
Market cap
$14.92B
Enterprise value
$16.53B
Valuations
Price to earnings (P/E)
34.41
Price to book (P/B)
3.86
Price to sales (P/S)
4.88
EV/EBIT
29.28
EV/EBITDA
21.31
EV/Sales
5.41
Earnings
Revenue
$3.06B
EBIT
$564.59M
EBITDA
$775.72M
Free cash flow
$479.84M
Per share
EPS
$5.08
Free cash flow per share
$5.62
Book value per share
$45.32
Revenue per share
$35.83
TBVPS
$30.59
Balance sheet
Total assets
$6.58B
Total liabilities
$2.7B
Debt
$1.86B
Equity
$3.87B
Working capital
$670.21M
Liquidity
Debt to equity
0.48
Current ratio
2.32
Quick ratio
1.6
Net debt/EBITDA
2.08
Margins
EBITDA margin
25.4%
Gross margin
43.4%
Net margin
14.1%
Operating margin
18.3%
Efficiency
Return on assets
7.6%
Return on equity
12%
Return on invested capital
18%
Return on capital employed
9.3%
Return on sales
18.5%
Dividend
Dividend yield
0.9%
DPS
$1.57
Payout ratio
30.9%

STE stock price

How has the STERIS stock price performed over time
Intraday
1.05%
1 week
-2.2%
1 month
-9.51%
1 year
5.66%
YTD
-7.78%
QTD
-7.78%

Financial performance

How have STERIS's revenue and profit performed over time
Revenue
$3.06B
Gross profit
$1.33B
Operating income
$560.06M
Net income
$431.87M
Gross margin
43.4%
Net margin
14.1%
The company's net income rose by 10% YoY and by 2.3% QoQ
STE's operating income is up by 8% YoY
STERIS's net margin has increased by 7% YoY
STE's operating margin is up by 4.6% year-on-year

Growth

What is STERIS's growth rate over time

Valuation

What is STERIS stock price valuation
P/E
34.41
P/B
3.86
P/S
4.88
EV/EBIT
29.28
EV/EBITDA
21.31
EV/Sales
5.41
The company's EPS rose by 9% YoY and by 2% QoQ
STE's P/E is 8% below its 5-year quarterly average of 37.6 but 3.3% above its last 4 quarters average of 33.3
STE's P/B is 29% above its 5-year quarterly average of 3.0
The company's equity rose by 14% YoY and by 6% QoQ
The P/S is 39% above the 5-year quarterly average of 3.5 and 6% above the last 4 quarters average of 4.6
The revenue has grown by 2.7% YoY

Efficiency

How efficient is STERIS business performance
STERIS's ROIC has decreased by 6% from the previous quarter
The company's return on sales rose by 4.5% YoY
STERIS's ROA has decreased by 2.6% from the previous quarter

Dividends

What is STE's dividend history
DPS
$1.57
Dividend yield
0.9%
Payout ratio
30.9%
Recent dividends

Financial health

How did STERIS financials performed over time
The total assets is 143% more than the total liabilities
STE's total liabilities is up by 48% since the previous quarter and by 39% year-on-year
The total assets has grown by 23% YoY and by 20% from the previous quarter
STERIS's debt is 52% less than its equity
STERIS's debt has soared by 60% from the previous quarter and by 48% YoY
STE's debt to equity has surged by 50% since the previous quarter and by 30% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.